[

fabiflu

]

‘Gambhir got Covid meds for health camp that never was’

  • Officials privy to a probe by the drug controller’s office say that the BJP MP’s foundation used one letter to procure 2,500 tablets of Fabiflu at a time when the medicine was in short supply
A Covid-19 patient on oxygen support waits outside Lok Nayak Hospital in April. The city’s health care system crumbled under the pressure of an unprecedented rise in Covid cases in April-May, and shortage of medicines and oxygen.( Ajay Aggarwal /HT PHOTO)
A Covid-19 patient on oxygen support waits outside Lok Nayak Hospital in April. The city’s health care system crumbled under the pressure of an unprecedented rise in Covid cases in April-May, and shortage of medicines and oxygen.( Ajay Aggarwal /HT PHOTO)
Published on Aug 18, 2021 06:31 AM IST
Copy Link
By Prawesh Lama, Hindustan Times, New Delhi

Cipla’s antiviral drug Cipremi joins Fabiflu, Covifor to treat Covid-19 infection

Remdesivir, happens to be the only USFDA approved Emergency Use Authorisation (EUA) treatment for adults and children hospitalised with suspected or laboratory confirmed coronavirus infection.
So that coronavirus patients can get quick access to this treatment and in anticipation of high demand, Cipla will be commercializing Remdesivir through its own facilities and partnered sites, the company statement said.(REUTERS PHOTO.)
So that coronavirus patients can get quick access to this treatment and in anticipation of high demand, Cipla will be commercializing Remdesivir through its own facilities and partnered sites, the company statement said.(REUTERS PHOTO.)
Updated on Jun 22, 2020 03:36 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar

After FabiFlu, Hetero’s antiviral drug Covifor gets DCGI approval to treat Covid-19 patients

COVIFOR will be available in 100 mg vials (injectable) which needs to be administered intravenously in a hospital facility under the proper supervision of a doctor or trained healthcare worker.
Vials of investigational Covid-19 treatment drug Remdesivir being capped at a Gilead Sciences facility in California in the United States.(REUTERS PHOTO.)
Vials of investigational Covid-19 treatment drug Remdesivir being capped at a Gilead Sciences facility in California in the United States.(REUTERS PHOTO.)
Updated on Jun 21, 2020 03:47 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar

Glenmark’s FabiFlu gets DCGI nod as Covid-19 drug, in stores next week: All you need to know

Bringing some relief for Covid-19 patients, even as the country reported an all-time high of 14,516 new coronavirus cases on Saturday, the drug will soon be available in hospitals and stores in a pack of 34 oral tables at moderately affordable prices.
The medicine can be administered to coronavirus patients between the age group of 18 and 75.(BLOOMBERG PHOTO.)
The medicine can be administered to coronavirus patients between the age group of 18 and 75.(BLOOMBERG PHOTO.)
Updated on Jun 20, 2020 10:44 PM IST
Copy Link
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar
SHARE
Story Saved
×
Saved Articles
My Reads
Sign out
New Delhi 0C
Monday, October 18, 2021